Search Results - xialing+cao

1 Results

Sort By:

Targeting Treatment For ADAM30 In Pathological Cells

Reference #: 01462 The University of South Carolina is offering licensing opportunities for Targeting treatment for ADAM30 in pathological cells Background: The treatment options for vascular malformations include conservative management, drug treatment, interventional radiology, laser therapy, excisional surgery and psychological treatment. However,...

Published: 9/3/2024 | Inventor(s): Wenbin Tan, Elaine Taine, Hui Wang, Vi Nguyen, Xialing Cao

Keywords(s): a disintegrin and metalloprotease (ADAM), antibody, biomarker, cancer, inhibitor, vascular malformation

Category(s): Health Sciences, Biomedical and Life Sciences